Combining Lymphoma Molecular Profiles, Microenvironment Signatures May Improve Prognosis

A research collaboration between biomedical software startup BostonGene and Weill Cornell Medicine has found that the tumor microenvironment influences the prognosis of patients with diffuse large B-cell lymphoma (DLBCL), suggesting that genomics alone may not provide a complete picture of a patient’s disease trajectory.